JP2024545441A5 - - Google Patents
Info
- Publication number
- JP2024545441A5 JP2024545441A5 JP2024533245A JP2024533245A JP2024545441A5 JP 2024545441 A5 JP2024545441 A5 JP 2024545441A5 JP 2024533245 A JP2024533245 A JP 2024533245A JP 2024533245 A JP2024533245 A JP 2024533245A JP 2024545441 A5 JP2024545441 A5 JP 2024545441A5
- Authority
- JP
- Japan
- Prior art keywords
- closely related
- composition according
- species
- sequence
- related species
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2030011 | 2021-12-03 | ||
| NL2030011A NL2030011B1 (en) | 2021-12-03 | 2021-12-03 | Prevention or treatment of hepatic steatosis |
| PCT/EP2022/083885 WO2023099579A1 (en) | 2021-12-03 | 2022-11-30 | Prevention or treatment of hepatic steatosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545441A JP2024545441A (ja) | 2024-12-06 |
| JP2024545441A5 true JP2024545441A5 (enExample) | 2025-12-10 |
Family
ID=80448857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533245A Pending JP2024545441A (ja) | 2021-12-03 | 2022-11-30 | 脂肪肝の予防、及び治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250025517A1 (enExample) |
| EP (1) | EP4440588A1 (enExample) |
| JP (1) | JP2024545441A (enExample) |
| CN (1) | CN118660712A (enExample) |
| NL (1) | NL2030011B1 (enExample) |
| TW (1) | TW202332457A (enExample) |
| WO (1) | WO2023099579A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025077370A1 (zh) * | 2023-10-12 | 2025-04-17 | 雷文虎克生物技术股份有限公司 | 艾克曼嗜黏蛋白菌及其用于预防非酒精性脂肪肝炎的用途 |
| WO2025229145A1 (en) | 2024-05-02 | 2025-11-06 | Stichting Amsterdam UMC | Desulfovibrio piger species for prevention or treatment of hepatic steatosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3140096A1 (en) * | 2019-05-21 | 2020-11-26 | Pendulum Therapeutics, Inc. | Methods and compositions for treating liver disorders |
| WO2021204719A1 (en) | 2020-04-07 | 2021-10-14 | Wholefiber Holding B.V. | Particles comprising inulin for use as medicament or supplement |
-
2021
- 2021-12-03 NL NL2030011A patent/NL2030011B1/en active
-
2022
- 2022-11-30 JP JP2024533245A patent/JP2024545441A/ja active Pending
- 2022-11-30 CN CN202280079735.0A patent/CN118660712A/zh active Pending
- 2022-11-30 US US18/713,999 patent/US20250025517A1/en active Pending
- 2022-11-30 EP EP22823493.6A patent/EP4440588A1/en active Pending
- 2022-11-30 WO PCT/EP2022/083885 patent/WO2023099579A1/en not_active Ceased
- 2022-12-01 TW TW111146093A patent/TW202332457A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abatenh et al. | Health benefits of probiotics | |
| Parvez et al. | Probiotics and their fermented food products are beneficial for health | |
| Fooks et al. | Probiotics as modulators of the gut flora | |
| Kalantzopoulos | Fermented products with probiotic qualities | |
| Holzapfel et al. | Introduction to pre-and probiotics | |
| Saxelin et al. | Probiotic and other functional microbes: from markets to mechanisms | |
| CA2837479C (en) | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
| Rabot et al. | Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism | |
| TWI594758B (zh) | 包含雙歧桿菌的組合物、其製備方法及其用途 | |
| Marteau et al. | Probiotics and health: new facts and ideas | |
| RU2011150216A (ru) | Детские питательные смеси, содержащие пробиотические микроорганизмы | |
| JP2013507394A5 (enExample) | ||
| KR102825170B1 (ko) | 프로바이오틱 비피도박테리움 브레베 균주 및 상기 균주를 포함하는 조성물 | |
| Putta et al. | Probiotics: supplements, food, pharmaceutical industry | |
| JP2009511469A (ja) | 脂肪代謝及び肥満に影響を及ぼすプロバイオティクス | |
| JP7126004B2 (ja) | 組成物及びその使用 | |
| Tomičić et al. | Beneficial properties of probiotic yeast Saccharomyces boulardii | |
| HRP20180053T1 (hr) | Novi soj bakterije bifidobacterium animalis subsp. lactis cect 8145 i njegova upotreba u liječenju i/ili sprječavanju prekomjerne težine i pretilosti, te bolesti povezanih s njima | |
| CN111956676A (zh) | 一种包含人参提取物和益生菌的微生态制剂及其制备方法和应用 | |
| JP2022533672A5 (enExample) | ||
| RU2013126609A (ru) | Экструдированные нереплицирующиеся пробиотические микроорганизмы и их польза для здоровья | |
| JP2024545441A5 (enExample) | ||
| Khatun et al. | Emerging role of probiotics in advancement of combating physical abnormalities and diseases: a systematic perspective analysis | |
| Vijaya Kumar et al. | Beneficial effects of probiotics and prebiotics on human health | |
| CN120390793A (zh) | 黏膜乳杆菌和需要glp-1增加的疾病 |